Based on the Opioid-Induced Constipation market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Opioid-Induced Constipation market covered in Chapter 5:

Cosmo Pharmaceuticals

Progenics Pharmaceuticals

Nektar Therapeutics

Mundipharma

AstraZeneca

Bayer

Boehringer Ingelheim

SLA Pharma

Daiichi Sankyo

Shionogi

Merck

Pfizer

Abbott

Valeant Pharmaceuticals International

Theravance

GlaxoSmithKline

Johnson and Johnson

Daewoong

C.B. Fleet

Synergy Pharmaceuticals

Takeda Pharmaceutical

Sucampo

Ironwood Pharmaceuticals

In Chapter 6, on the basis of types, the Opioid-Induced Constipation market from 2015 to 2025 is primarily split into:

Oral

Parenteral

In Chapter 7, on the basis of applications, the Opioid-Induced Constipation market from 2015 to 2025 covers:

Drugstore

Hospital

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Opioid-Induced Constipation Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 Cosmo Pharmaceuticals

5.1.1 Cosmo Pharmaceuticals Company Profile

5.1.2 Cosmo Pharmaceuticals Business Overview

5.1.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.1.4 Cosmo Pharmaceuticals Opioid-Induced Constipation Products Introduction

5.2 Progenics Pharmaceuticals

5.2.1 Progenics Pharmaceuticals Company Profile

5.2.2 Progenics Pharmaceuticals Business Overview

5.2.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.2.4 Progenics Pharmaceuticals Opioid-Induced Constipation Products Introduction

5.3 Nektar Therapeutics

5.3.1 Nektar Therapeutics Company Profile

5.3.2 Nektar Therapeutics Business Overview

5.3.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.3.4 Nektar Therapeutics Opioid-Induced Constipation Products Introduction

5.4 Mundipharma

5.4.1 Mundipharma Company Profile

5.4.2 Mundipharma Business Overview

5.4.3 Mundipharma Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.4.4 Mundipharma Opioid-Induced Constipation Products Introduction

5.5 AstraZeneca

5.5.1 AstraZeneca Company Profile

5.5.2 AstraZeneca Business Overview

5.5.3 AstraZeneca Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.5.4 AstraZeneca Opioid-Induced Constipation Products Introduction

5.6 Bayer

5.6.1 Bayer Company Profile

5.6.2 Bayer Business Overview

5.6.3 Bayer Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.6.4 Bayer Opioid-Induced Constipation Products Introduction

5.7 Boehringer Ingelheim

5.7.1 Boehringer Ingelheim Company Profile

5.7.2 Boehringer Ingelheim Business Overview

5.7.3 Boehringer Ingelheim Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.7.4 Boehringer Ingelheim Opioid-Induced Constipation Products Introduction

5.8 SLA Pharma

5.8.1 SLA Pharma Company Profile

5.8.2 SLA Pharma Business Overview

5.8.3 SLA Pharma Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.8.4 SLA Pharma Opioid-Induced Constipation Products Introduction

5.9 Daiichi Sankyo

5.9.1 Daiichi Sankyo Company Profile

5.9.2 Daiichi Sankyo Business Overview

5.9.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.9.4 Daiichi Sankyo Opioid-Induced Constipation Products Introduction

5.10 Shionogi

5.10.1 Shionogi Company Profile

5.10.2 Shionogi Business Overview

5.10.3 Shionogi Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.10.4 Shionogi Opioid-Induced Constipation Products Introduction

5.11 Merck

5.11.1 Merck Company Profile

5.11.2 Merck Business Overview

5.11.3 Merck Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.11.4 Merck Opioid-Induced Constipation Products Introduction

5.12 Pfizer

5.12.1 Pfizer Company Profile

5.12.2 Pfizer Business Overview

5.12.3 Pfizer Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.12.4 Pfizer Opioid-Induced Constipation Products Introduction

5.13 Abbott

5.13.1 Abbott Company Profile

5.13.2 Abbott Business Overview

5.13.3 Abbott Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.13.4 Abbott Opioid-Induced Constipation Products Introduction

5.14 Valeant Pharmaceuticals International

5.14.1 Valeant Pharmaceuticals International Company Profile

5.14.2 Valeant Pharmaceuticals International Business Overview

5.14.3 Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.14.4 Valeant Pharmaceuticals International Opioid-Induced Constipation Products Introduction

5.15 Theravance

5.15.1 Theravance Company Profile

5.15.2 Theravance Business Overview

5.15.3 Theravance Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.15.4 Theravance Opioid-Induced Constipation Products Introduction

5.16 GlaxoSmithKline

5.16.1 GlaxoSmithKline Company Profile

5.16.2 GlaxoSmithKline Business Overview

5.16.3 GlaxoSmithKline Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.16.4 GlaxoSmithKline Opioid-Induced Constipation Products Introduction

5.17 Johnson and Johnson

5.17.1 Johnson and Johnson Company Profile

5.17.2 Johnson and Johnson Business Overview

5.17.3 Johnson and Johnson Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.17.4 Johnson and Johnson Opioid-Induced Constipation Products Introduction

5.18 Daewoong

5.18.1 Daewoong Company Profile

5.18.2 Daewoong Business Overview

5.18.3 Daewoong Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.18.4 Daewoong Opioid-Induced Constipation Products Introduction

5.19 C.B. Fleet

5.19.1 C.B. Fleet Company Profile

5.19.2 C.B. Fleet Business Overview

5.19.3 C.B. Fleet Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.19.4 C.B. Fleet Opioid-Induced Constipation Products Introduction

5.20 Synergy Pharmaceuticals

5.20.1 Synergy Pharmaceuticals Company Profile

5.20.2 Synergy Pharmaceuticals Business Overview

5.20.3 Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.20.4 Synergy Pharmaceuticals Opioid-Induced Constipation Products Introduction

5.21 Takeda Pharmaceutical

5.21.1 Takeda Pharmaceutical Company Profile

5.21.2 Takeda Pharmaceutical Business Overview

5.21.3 Takeda Pharmaceutical Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.21.4 Takeda Pharmaceutical Opioid-Induced Constipation Products Introduction

5.22 Sucampo

5.22.1 Sucampo Company Profile

5.22.2 Sucampo Business Overview

5.22.3 Sucampo Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.22.4 Sucampo Opioid-Induced Constipation Products Introduction

5.23 Ironwood Pharmaceuticals

5.23.1 Ironwood Pharmaceuticals Company Profile

5.23.2 Ironwood Pharmaceuticals Business Overview

5.23.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.23.4 Ironwood Pharmaceuticals Opioid-Induced Constipation Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global Opioid-Induced Constipation Sales and Market Share by Types (2015-2020)

6.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Types (2015-2020)

6.1.3 Global Opioid-Induced Constipation Price by Types (2015-2020)

6.2 Global Opioid-Induced Constipation Market Forecast by Types (2020-2025)

6.2.1 Global Opioid-Induced Constipation Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global Opioid-Induced Constipation Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global Opioid-Induced Constipation Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global Opioid-Induced Constipation Sales, Price and Growth Rate of Oral

6.3.2 Global Opioid-Induced Constipation Sales, Price and Growth Rate of Parenteral

6.4 Global Opioid-Induced Constipation Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 Oral Market Revenue and Sales Forecast (2020-2025)

6.4.2 Parenteral Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global Opioid-Induced Constipation Sales and Market Share by Applications (2015-2020)

7.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Applications (2015-2020)

7.2 Global Opioid-Induced Constipation Market Forecast by Applications (2020-2025)

7.2.1 Global Opioid-Induced Constipation Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global Opioid-Induced Constipation Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global Opioid-Induced Constipation Revenue, Sales and Growth Rate of Drugstore (2015-2020)

7.3.2 Global Opioid-Induced Constipation Revenue, Sales and Growth Rate of Hospital (2015-2020)

7.3.3 Global Opioid-Induced Constipation Revenue, Sales and Growth Rate of Others (2015-2020)

7.4 Global Opioid-Induced Constipation Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Drugstore Market Revenue and Sales Forecast (2020-2025)

7.4.2 Hospital Market Revenue and Sales Forecast (2020-2025)

7.4.3 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global Opioid-Induced Constipation Sales by Regions (2015-2020)

8.2 Global Opioid-Induced Constipation Market Revenue by Regions (2015-2020)

8.3 Global Opioid-Induced Constipation Market Forecast by Regions (2020-2025)

9 North America Opioid-Induced Constipation Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

9.3 North America Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

9.4 North America Opioid-Induced Constipation Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America Opioid-Induced Constipation Market Analysis by Country

9.6.1 U.S. Opioid-Induced Constipation Sales and Growth Rate

9.6.2 Canada Opioid-Induced Constipation Sales and Growth Rate

9.6.3 Mexico Opioid-Induced Constipation Sales and Growth Rate

10 Europe Opioid-Induced Constipation Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

10.3 Europe Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

10.4 Europe Opioid-Induced Constipation Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe Opioid-Induced Constipation Market Analysis by Country

10.6.1 Germany Opioid-Induced Constipation Sales and Growth Rate

10.6.2 United Kingdom Opioid-Induced Constipation Sales and Growth Rate

10.6.3 France Opioid-Induced Constipation Sales and Growth Rate

10.6.4 Italy Opioid-Induced Constipation Sales and Growth Rate

10.6.5 Spain Opioid-Induced Constipation Sales and Growth Rate

10.6.6 Russia Opioid-Induced Constipation Sales and Growth Rate

11 Asia-Pacific Opioid-Induced Constipation Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific Opioid-Induced Constipation Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific Opioid-Induced Constipation Market Analysis by Country

11.6.1 China Opioid-Induced Constipation Sales and Growth Rate

11.6.2 Japan Opioid-Induced Constipation Sales and Growth Rate

11.6.3 South Korea Opioid-Induced Constipation Sales and Growth Rate

11.6.4 Australia Opioid-Induced Constipation Sales and Growth Rate

11.6.5 India Opioid-Induced Constipation Sales and Growth Rate

12 South America Opioid-Induced Constipation Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

12.3 South America Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

12.4 South America Opioid-Induced Constipation Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America Opioid-Induced Constipation Market Analysis by Country

12.6.1 Brazil Opioid-Induced Constipation Sales and Growth Rate

12.6.2 Argentina Opioid-Induced Constipation Sales and Growth Rate

12.6.3 Columbia Opioid-Induced Constipation Sales and Growth Rate

13 Middle East and Africa Opioid-Induced Constipation Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa Opioid-Induced Constipation Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa Opioid-Induced Constipation Market Analysis by Country

13.6.1 UAE Opioid-Induced Constipation Sales and Growth Rate

13.6.2 Egypt Opioid-Induced Constipation Sales and Growth Rate

13.6.3 South Africa Opioid-Induced Constipation Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Opioid-Induced Constipation Market Size and Growth Rate 2015-2025

Table Opioid-Induced Constipation Key Market Segments

Figure Global Opioid-Induced Constipation Market Revenue ($) Segment by Type from 2015-2020

Figure Global Opioid-Induced Constipation Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Opioid-Induced Constipation

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Cosmo Pharmaceuticals Company Profile

Table Cosmo Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Cosmo Pharmaceuticals Production and Growth Rate

Figure Cosmo Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Progenics Pharmaceuticals Company Profile

Table Progenics Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Progenics Pharmaceuticals Production and Growth Rate

Figure Progenics Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Nektar Therapeutics Company Profile

Table Nektar Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Nektar Therapeutics Production and Growth Rate

Figure Nektar Therapeutics Market Revenue ($) Market Share 2015-2020

Table Mundipharma Company Profile

Table Mundipharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Mundipharma Production and Growth Rate

Figure Mundipharma Market Revenue ($) Market Share 2015-2020

Table AstraZeneca Company Profile

Table AstraZeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure AstraZeneca Production and Growth Rate

Figure AstraZeneca Market Revenue ($) Market Share 2015-2020

Table Bayer Company Profile

Table Bayer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bayer Production and Growth Rate

Figure Bayer Market Revenue ($) Market Share 2015-2020

Table Boehringer Ingelheim Company Profile

Table Boehringer Ingelheim Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Boehringer Ingelheim Production and Growth Rate

Figure Boehringer Ingelheim Market Revenue ($) Market Share 2015-2020

Table SLA Pharma Company Profile

Table SLA Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure SLA Pharma Production and Growth Rate

Figure SLA Pharma Market Revenue ($) Market Share 2015-2020

Table Daiichi Sankyo Company Profile

Table Daiichi Sankyo Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Daiichi Sankyo Production and Growth Rate

Figure Daiichi Sankyo Market Revenue ($) Market Share 2015-2020

Table Shionogi Company Profile

Table Shionogi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Shionogi Production and Growth Rate

Figure Shionogi Market Revenue ($) Market Share 2015-2020

Table Merck Company Profile

Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Merck Production and Growth Rate

Figure Merck Market Revenue ($) Market Share 2015-2020

Table Pfizer Company Profile

Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer Production and Growth Rate

Figure Pfizer Market Revenue ($) Market Share 2015-2020

Table Abbott Company Profile

Table Abbott Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Abbott Production and Growth Rate

Figure Abbott Market Revenue ($) Market Share 2015-2020

Table Valeant Pharmaceuticals International Company Profile

Table Valeant Pharmaceuticals International Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Valeant Pharmaceuticals International Production and Growth Rate

Figure Valeant Pharmaceuticals International Market Revenue ($) Market Share 2015-2020

Table Theravance Company Profile

Table Theravance Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Theravance Production and Growth Rate

Figure Theravance Market Revenue ($) Market Share 2015-2020

Table GlaxoSmithKline Company Profile

Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GlaxoSmithKline Production and Growth Rate

Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020

Table Johnson and Johnson Company Profile

Table Johnson and Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Johnson and Johnson Production and Growth Rate

Figure Johnson and Johnson Market Revenue ($) Market Share 2015-2020

Table Daewoong Company Profile

Table Daewoong Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Daewoong Production and Growth Rate

Figure Daewoong Market Revenue ($) Market Share 2015-2020

Table C.B. Fleet Company Profile

Table C.B. Fleet Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure C.B. Fleet Production and Growth Rate

Figure C.B. Fleet Market Revenue ($) Market Share 2015-2020

Table Synergy Pharmaceuticals Company Profile

Table Synergy Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Synergy Pharmaceuticals Production and Growth Rate

Figure Synergy Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Takeda Pharmaceutical Company Profile

Table Takeda Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Takeda Pharmaceutical Production and Growth Rate

Figure Takeda Pharmaceutical Market Revenue ($) Market Share 2015-2020

Table Sucampo Company Profile

Table Sucampo Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sucampo Production and Growth Rate

Figure Sucampo Market Revenue ($) Market Share 2015-2020

Table Ironwood Pharmaceuticals Company Profile

Table Ironwood Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Ironwood Pharmaceuticals Production and Growth Rate

Figure Ironwood Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Global Opioid-Induced Constipation Sales by Types (2015-2020)

Table Global Opioid-Induced Constipation Sales Share by Types (2015-2020)

Table Global Opioid-Induced Constipation Revenue ($) by Types (2015-2020)

Table Global Opioid-Induced Constipation Revenue Share by Types (2015-2020)

Table Global Opioid-Induced Constipation Price ($) by Types (2015-2020)

Table Global Opioid-Induced Constipation Market Forecast Sales by Types (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Sales Share by Types (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Revenue ($) by Types (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Revenue Share by Types (2020-2025)

Figure Global Oral Sales and Growth Rate (2015-2020)

Figure Global Oral Price (2015-2020)

Figure Global Parenteral Sales and Growth Rate (2015-2020)

Figure Global Parenteral Price (2015-2020)

Figure Global Opioid-Induced Constipation Market Revenue ($) and Growth Rate Forecast of Oral (2020-2025)

Figure Global Opioid-Induced Constipation Sales and Growth Rate Forecast of Oral (2020-2025)

Figure Global Opioid-Induced Constipation Market Revenue ($) and Growth Rate Forecast of Parenteral (2020-2025)

Figure Global Opioid-Induced Constipation Sales and Growth Rate Forecast of Parenteral (2020-2025)

Table Global Opioid-Induced Constipation Sales by Applications (2015-2020)

Table Global Opioid-Induced Constipation Sales Share by Applications (2015-2020)

Table Global Opioid-Induced Constipation Revenue ($) by Applications (2015-2020)

Table Global Opioid-Induced Constipation Revenue Share by Applications (2015-2020)

Table Global Opioid-Induced Constipation Market Forecast Sales by Applications (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Sales Share by Applications (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Drugstore Sales and Growth Rate (2015-2020)

Figure Global Drugstore Price (2015-2020)

Figure Global Hospital Sales and Growth Rate (2015-2020)

Figure Global Hospital Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Opioid-Induced Constipation Market Revenue ($) and Growth Rate Forecast of Drugstore (2020-2025)

Figure Global Opioid-Induced Constipation Sales and Growth Rate Forecast of Drugstore (2020-2025)

Figure Global Opioid-Induced Constipation Market Revenue ($) and Growth Rate Forecast of Hospital (2020-2025)

Figure Global Opioid-Induced Constipation Sales and Growth Rate Forecast of Hospital (2020-2025)

Figure Global Opioid-Induced Constipation Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Opioid-Induced Constipation Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Table Global Opioid-Induced Constipation Sales by Regions (2015-2020)

Table Global Opioid-Induced Constipation Sales Market Share by Regions (2015-2020)

Figure Global Opioid-Induced Constipation Sales Market Share by Regions in 2019

Figure Global Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)

Table Global Opioid-Induced Constipation Revenue by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue Market Share by Regions (2015-2020)

Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2019

Table Global Opioid-Induced Constipation Market Forecast Sales by Regions (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Sales Share by Regions (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Opioid-Induced Constipation Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure North America Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

Figure North America Opioid-Induced Constipation Market Forecast Sales (2020-2025)

Figure North America Opioid-Induced Constipation Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Canada Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Mexico Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Market Forecast Sales (2020-2025)

Figure Europe Opioid-Induced Constipation Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure France Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Italy Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Spain Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Russia Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Opioid-Induced Constipation Market Forecast Sales (2020-2025)

Figure Asia-Pacific Opioid-Induced Constipation Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Japan Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure South Korea Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Australia Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure India Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Market Forecast Sales (2020-2025)

Figure South America Opioid-Induced Constipation Market Forecast Revenue ($) (2020-2025)

Figure Brazil Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Argentina Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Columbia Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Market Forecast Sales (2020-2025)

Figure Middle East and Africa Opioid-Induced Constipation Market Forecast Revenue ($) (2020-2025)

Figure UAE Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure Egypt Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Figure South Africa Opioid-Induced Constipation Market Sales and Growth Rate (2015-2020)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)